U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178093) titled 'Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization' on April 28, 2023.
Brief Summary: Effects of Antrodia cinnamomea on the hepatoma patients after Transcatheter hepatic artery chemoembolization
Study Start Date: Jan. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Hepatocellular Carcinoma
Transarterial Chemoembolization
Intervention:
DIETARY_SUPPLEMENT: Antrodia cinnamomea
The experiment lasted for 11 days, and patients were required to take Kangjian Antrodia cinnamomea 3 days before embolization, the day of embolization to the 7th day after surgery, once a day in the...